New diagnostic serum biomarkers for Chagas disease

Bibliography

• Moncayo A. Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. Mem Inst Oswaldo Cruz 2003;5:577-91
   Google Scholar
• Aufderheide AC, Salo W, Streitz J, A 9000 year record of Chagas' disease. Proc Natl Acad Sci USA 2004;101:2034-9
   PubMed Web of Science ®Google Scholar
• Zingales B, Andrade SG, Briones, MRS, A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. Mem Inst Oswaldo Cruz 2009;104:1051-4
   PubMed Web of Science ®Google Scholar
• Telleria J, Biron DG, Brizard JP, Phylogenetic character mapping of proteomic diversity shows high correlation with subspecific phylogenetic diversity in Trypanosoma cruzi. Proc Natl Acad Sci USA 2010;107:20411-16
   PubMed Web of Science ®Google Scholar
• WHO. Control of Chagas disease. World Health Organ. Tech Rep Ser 1991;811:1-95
   PubMedGoogle Scholar
• Schmunis GA. Epidemiology of Chagas' disease in non-endemic countries: the role of international migratin. Mem Inst Oswaldo Cruz 2007;102(Suppl I):75-85
   PubMedGoogle Scholar
• Pinto AY, Valente AS, Valente VC. Emerging acute Chagas' disease in amazonian Brazil: case reports of serious cardiac involvement. Braz J Infect Dis 2004;8:454-60
   PubMedGoogle Scholar
• Maguire JH, Hoff R, Sherlock I. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation 1987;75:1140-5
   PubMed Web of Science ®Google Scholar
• Dias JC, Kloetzel K. The prognostic value of the electrocardiographic features of chronic Chagas' disease. Rev Inst Med Trop Sao Paulo 1968;10:158-62
   PubMedGoogle Scholar
• Coura JR, Abreu LL, Pereira JB, Morbidity in Chagas' disease. IV. Longitudinal study of 10 years in Pains and Iguatama, Minas Gerais, Brazil. Mem Inst Osw Cruz 1985;80:73-80
   PubMedGoogle Scholar
• Primeira reuniao de pesquisa aplicada em doença de Chagas. Validade do conceito da forma indeterminada. Rev Soc Bras Med Trop 1985;18:46
   Google Scholar
• Ianni BM, Arteaga E, Frimm CC, Chagas' heart disease: evolutive evaluation of eletrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq Bras Cardiol 2001;77:59-62
   PubMedGoogle Scholar
• Mady C, Pereira-Barreto AC, Ianni BM. Right ventricular endomyocardial biopsy in undeterminated form of Chagas' diseae. Angiology 1984;35:755-9
   PubMed Web of Science ®Google Scholar
• Ortiz J, Pereira-Barretto AC, Matsumoto AY, Segmental contractily changes in the indeterminated form of Chagas' disease. Echocardiographic study. Arq Bras Cardiol 1987;49:217-20
   PubMedGoogle Scholar
• Prata A. Clinical and epidemiological aspects of Chagas' disease. Lancet Infect Dis 2001;1:92-100
   PubMedGoogle Scholar
• Marin-Neto JA, Simoes MV, Sarabanda AVL. Cardiopatia Chagasica. Arq Bras Cardiol 1999;72(3):247-62
   PubMedGoogle Scholar
• Rassi A Jr, Rassi A, Marin-Neto JA. Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification. Mem Inst Oswaldo Cruz 2009;104(Suppl I):152-8
   PubMedGoogle Scholar
• Mady C, Cardoso RH, Barretto AC, Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 1994;90:3098-102
   PubMed Web of Science ®Google Scholar
• Freitas HF, Chizzola PR, Paes AT, Risk stratification in a Brazilian hospital-based cohort of 1220 outpatients with heart failure: role of Chagas' disease. Int J Cardiol 2005;102:239-47
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV. Pathogenesis of chronic Chagas Heart Disease. Circulation 2007;115:1109-23
   PubMed Web of Science ®Google Scholar
• Marinho CR, D'Imperio MR, Grisotto MG, Influence of acute-phase parasite load on pathology, parasitism and activation of the immune system at the late chronic phase of Chagas' disease. Infect Immun 1999;67:308-18
   PubMed Web of Science ®Google Scholar
• Olivares-Villagomez D, McCurley TL, Vnencak-Jones CL, Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue. Am J Trop Med Hyg 1998;59:563-70
   PubMed Web of Science ®Google Scholar
• Bilate AMB, Cunha-Neto E. Chagas Disease Cardiomyopathy: current concepts of na old disease. Rev Inst Med Trop S Paulo 2008;50(2):67-74
   PubMed Web of Science ®Google Scholar
• Marin-Neto JA, Bromberg–Marin G, Pazin-Filho A, Cardiac autonomic impairment and early myocardial damage involving the right ventricle are independent phenomena in Chagas' disease. Int J Cardiol 1998;65:261-9
   PubMed Web of Science ®Google Scholar
• Soares Barreto-Filho JA, Consolim-Colombo FM, Ferreira LH, Dysregulation of peripheral and central chemoreflex responses in Chagas' heart disease patients without heart failure. Circulation 2001;104:1792-8
   PubMed Web of Science ®Google Scholar
• Ribeiro ALP, Moraes RS, Ribeiro JP, Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 2001;141:260-5
   PubMed Web of Science ®Google Scholar
• Molina RBG, Matsubara BB, Hueb JC, Dysautonoia and ventricular dysfunction in the ineterminate form of Chagas disease. Int J Cardiol 2006;113:188-93
   PubMed Web of Science ®Google Scholar
• Cunha AB. A doença de chagas e o envolvimento do Sistema Nervoso Autonomo. Rev Port Cardiol 2003;22:813-24
   PubMedGoogle Scholar
• Sterin-Borda L, Borda E. Role of neurotransmitter autoantibodies in the pathogenis of Chagasic peripheral dysautonomia. Ann NY Acad Sci 2000;917:273-80
   PubMed Web of Science ®Google Scholar
• Goin JC, Perez Leiros C, Borda E, Sterin-Borda L. Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications. FASEB J 1997;11:77-83
   PubMed Web of Science ®Google Scholar
• Pinho-Ribeiro AL, Diaz Gimenez LE, Quintero Hernandez CC, Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Intern J Cardiol 2007;117:59-63
   PubMed Web of Science ®Google Scholar
• Medei E, Pedrosa RC, Benchimol Barbosa PR, Human antibodies with muscarinic activity modulate ventricular repolarization: Basis for electrical disturbance. Int J Cardiol 2007;115:373-80
   PubMed Web of Science ®Google Scholar
• Garcia S, Ramos CO, Senra JFV, Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations. Am Soc Microbiol 2005;49:1521-8
   Google Scholar
• Hershko AY, Naparstek Y. Removal of pathogenic autoantibodies by immunoadsorption. Ann NY Acad Sci 2005;1051:635-46
   PubMed Web of Science ®Google Scholar
• Sterin-Borda L, Joensen L, Bayo-Hanza C, Therapeutic use of muscarinic acetylcholine receptor peptide to prevent mice chagasic cardiac dysfunction. J Mol Cell Cardiol 2002;34:1645-54
   PubMed Web of Science ®Google Scholar
• Carvalho KA, Guarita-Souza LC, Hansen P, Cell transplantation after the coculture of skeletal myoblasts and mesenchymal in the regeneration of the myocardium scar : an experimental study in rats. Transplant Proc 2006;38:1596-602
   PubMed Web of Science ®Google Scholar
• Richards AM. The natriuretic peptides in heart failure. Basic Res Cardiol 2004;99:94-100
   PubMed Web of Science ®Google Scholar
• Wang Y, Moreira MC, Heringer-Walther S, Amino-terminal fragment of C-Type natriuretic peptide precursor and C-type natriuretic peptide do not correlate in patients with Chagas' disease: role for neutral endopeptidase. J Cardiovasc Pharmacol 2010;55:62-6
   PubMed Web of Science ®Google Scholar
• Mady C, Fernandes F, Arteaga E, Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies. Arq Bras Cardiol 2008;91:46-50
   PubMed Web of Science ®Google Scholar
• Moreira MC, Wang Y, Heringer-Walther S. Prognostic value of natriuretic peptides in Chagas' disease: a head-to-head comparison of the 3 natriuretic peptides. Congest Heart Fail 2009;15:75-81
   PubMedGoogle Scholar
• Moreira MC, Heringer-Walther S, Wessel N, Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation. Cardiology 2008;110:217-25
   PubMed Web of Science ®Google Scholar
• Lima-Costa MF, Cesar CC, Peixoto SV, Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas' disease: 10-year follow-up of the Bambui cohort study of aging. Am J Epidem 2010;172:190-6
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Teixeira MM, Reis AM. Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas' disease: a comparison with the conventional approach. Int J Cardiol 2006;109:34-40
   PubMed Web of Science ®Google Scholar
• Fernandes F, Dantas S, Ianni BM, Leptin levels in different forms of Chagas'disease. Braz J Med Biol Res 2007;40:1631-6
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Duranti M, Gruber A, Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci USA 1995;92:3541-5
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Coelho V, Guilherme L, Autoimmunity in Chagas' disease: identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 1996;98(8):1709-12
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Bilate AM, Hyland KH, Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 2006;39(1):41-54
   PubMed Web of Science ®Google Scholar
• Reis MM, Higuchi ML, Benvenuti LA. An in situ quantitative immunohistochemical study of cytocines and IL-2Rin chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 1997;83:165-72
   PubMed Web of Science ®Google Scholar
• Cunha-Neto E, Rizzo LV, Albuquerque F, Cytokine production profile of heart-infiltrating T cells in Chagas' disease cardiomyopathy. Braz J Med Biol Res 1998;31:133-7
   PubMed Web of Science ®Google Scholar
• Ferreira RC, Ianni BI, Abel L, Increased plasma levels of Tumor Necrosis Factor in asymptomatic/indeterminate and Chagas disease Cardiomyopathy patients. Mem Inst Oswaldo Cruz 2003;98(3):407-11
   PubMed Web of Science ®Google Scholar
• Abel LCJ, Rizzo LV, Ianni B, Chronic Chagas' disease Cardiomyopathy patients display na increased IFN response to Trypanosoma cruzi infection. J Autoimmun 2001;17:99-108
   PubMed Web of Science ®Google Scholar
• Mocelin AM, Issa VS, Bacal F, The influence of aetiology on inflamatory and neurohumoral activation in patients with severe heart failure: a prospecive study comparing Chagas' heart disease and idiophatic dilated cardiomyopathy. Eur J Heart Fail 2005;7:869-73
   PubMed Web of Science ®Google Scholar
• Drigo SA, Cunha-Neto E, Ianni B, TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 2006;8:598-603
   PubMed Web of Science ®Google Scholar
• Bilate AM, Salemi VM, Ramires FJ, TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect 2007;9:1104-13
   PubMed Web of Science ®Google Scholar
• Rocha A, Oliveira LCM, Alves RS, Despopulaçao neuronal pancreatica em chagasicos cronicos. Rev Soc Bras Med Trop 1998;31(1):43-9
   PubMedGoogle Scholar
• Saldanha JC, Santos VM, Reis MA, Morphologic and morphometric evaluation of pancreatic islets in chronic Chagas'Disease. Rev Hosp Clin Fac Med S Paulo 2001;56(5):131-8
   PubMedGoogle Scholar
• Santos VM, Lima MA, Cabrine-Santos M, Functional and histopathological study of the pancreas in hamsters (Mesocrisetus Auratus) infected and reinfected with Trypanosoma Cruzi. Parasitol Res 2004;94:125-33
   PubMed Web of Science ®Google Scholar
• Oliveira LCM, Juliano Y, Novo NF, Blood glucose and insulin response to intravenous glucose by patients with chronic Chagas' Disease and alcoholism. Braz J Med Biol Res 1993;26:1187-90
   PubMed Web of Science ®Google Scholar
• Guariento ME, Saad MJA, Muscelli EOA, Heterogeneous insulin response to an oral glucose load by patients with indeterminate clinical form of Chagas' Disease. Braz J Med Biol Res 1993;26:491-5
   PubMed Web of Science ®Google Scholar
• Guariento ME, Muscelli EOA, Gontijo JAR. Chronotropic and blood pressure response to oral glucose load in Chagas Disease. Sao Paulo Med J 1994;112(3):602-6
   PubMedGoogle Scholar
• Santos VM, Cunha SFC, Teixeira VPA, Frequencia de diabetes mellitus e hiperglicemia em mulheres chagásicas e nao-chagasicas. Rev Soc Bras Med Trop 1999;32(5):489-96
   PubMedGoogle Scholar
• Geraix J, Ardisson LP, Marcondes-Machado J, Clinical and nutritional profile of individuals with Chagas Disease. Braz J Infect Dis 2007;11(4):411-14
   PubMed Web of Science ®Google Scholar
• Wajchenberg BL, Nery M, Cunha MR, Adipose tissue at the crossroads in the development of the metabolic syndrome, inflammation and atherosclerosis. Arq Bras Endocrinol Metab 2009;53:145-50
   PubMed Web of Science ®Google Scholar
• Desrusseaux MS, Nagajyothi F, Trujillo ME, Adipocyte, adipose tissue and infectious disease. Infect Immun 2007;3:1066-78
   Google Scholar
• Stolf NA, Higushi L, Bocchi E, Heart transplantation in patients with Chagas Disease Cardiomyopathy. J Heart Transplant 1987;6:307-12
   PubMedGoogle Scholar
• Andrade ZA, Silva HR. Parasitism of adipocytes by Trypanosoma cruzi. Mem Inst Oswaldo Cruz 1995;90:521-2
   PubMed Web of Science ®Google Scholar
• Coombs TP, Mukherjee S, Almeida CJG, The adipocyte as an important target cell for infection with Trypanosoma cruzi. J Biol Chem 2005;280:24085-94
   PubMed Web of Science ®Google Scholar
• Nagajyothi F, Desruisseaux MS, Thiruvur N, Trypanosoma cruzi infection of cultured adipocytes results in an inflammatory phenotype. Obesity 2008;16:1992-7
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mangalat D, Korbut R. Adipocytokines- Novel link between inflamation and vascular function? J Physiol Pharmacol 2006;57(4):505-28
   PubMed Web of Science ®Google Scholar
• Berg AH, Scherer PE. Adipose tissue, inflammation and cardiovascular disease. Circulation Res 2005;96:939-49
   PubMed Web of Science ®Google Scholar
• Wolk R, Johnson BD, Somers VK. Leptin and the ventilatory response to exercise in heart failure. J Am Coll Cardiol 2003;42:1644-9
   PubMed Web of Science ®Google Scholar
• Grassi G. Leptin, sympathetic nervous system and baroreflex function. Curr Hypertens Rep 2004;6:236-40
   PubMed Web of Science ®Google Scholar
• Schulze PC, Kratzsch J. Leptin as a new diagnostic tool in chronic heart failure. Clin Chim Acta 2005;362:1-11
   PubMed Web of Science ®Google Scholar
• Schulze PC, Kratzsch J, Linke A, Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail 2003;5:33-40
   PubMed Web of Science ®Google Scholar
• Richartz BM, Lotze U, Krack A, Leptin: a parameter for metabolic changes in heart failure. Z Cardiol 2001;90:280-5
   PubMedGoogle Scholar
• Ndao M, Spithill TW, Caffrey R, Identification of novel diagnostic serum biomarkers for Chagas' disease in asymptomatic subjects by mass spectrometric profiling. J Clin Microbiol 2010;48:1139-49
   PubMed Web of Science ®Google Scholar